Degradation of porstaglandin F2alpha in the human pulmonary circulation.
about
Influence of endothelium and surgical preparation on responses of human saphenous vein and internal thoracic artery to angiotensin IIDetection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay.Inhibition by glucocorticoids of prostaglandin release from adipose tissue in vitro.A pharmacological study of the mediators released following anaphylaxis of the sensitised hind quarters of the guinea-pig [proceedings]The effect of vitamin C deficiency and supplementation on the weight pattern and skin potential of the guinea-pig [proceedings]The effects of glucocorticoids on the distribution and mobilisation of arachidonic acid in fat cell ghosts.Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine.The release of prostaglandins and thromboxanes from guinea-pig lung by slow reacting substance of anaphylaxis, and its inhibition.Kinetics of the generation and action of chemical mediators in zymosan-induced inflammation of the rabbit peritoneal cavity.Effect of cyclosporin A and inhibitors of arachidonic acid metabolism on blood flow and cyclo-oxygenase products in rat skin allograftsEffects of vasoactive intestinal peptide, helodermin and galanin on responses of guinea-pig lung parenchyma to histamine, acetylcholine and leukotriene D4.Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4.The role of the epithelium in modulating the responses of guinea-pig trachea induced by bradykinin in vitro.Effect of K+ channel-modulating drugs on the vasoconstrictor responses of leukotrienes C4, D4 and angiotensin II in the guinea-pig isolated perfused heart.Inhibition of leukotriene release in anaphylactic guinea-pig hearts by a 5-lipoxygenase inhibitor, CGS 8515.Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination.
P2860
Q34346494-04544250-0694-43CC-8C85-603883C6AE45Q34416457-A9CE4174-D46B-4F9A-ACA5-50B16A1F52D2Q35177361-2851B42E-A8CD-4A60-866A-FFEA11FD6A37Q36096076-185EEAA4-EBD6-48B7-AB70-EC0E6DF4413DQ36096346-EE7E9CD8-D4DF-4516-9CD1-A101410AE6D9Q36096396-31E8E724-22EB-4BDA-ABD8-E0BF293FC13FQ39470204-33816068-DB86-49A6-AEEC-DE40D1F285B4Q40053387-D21DCD26-EC50-4A3B-8D8C-A860D6305F16Q41480005-4D150958-56E7-4380-9F02-86A7D5FB28E6Q41747256-4BE12E26-8E5D-4FFB-B020-B4E34B49F3FAQ41836317-820593B2-5FA5-4B38-9C5A-7AD83F6800E7Q41854416-28467758-16B9-41D5-8968-ED512A709BCAQ42071467-EF040826-92D9-4B08-8C2F-C7DC7C28C939Q42712128-17C7BF0F-0F94-4433-ADFA-121F9A952B66Q42848398-C92E97F9-C87A-443E-A983-C2004337BC7FQ44858911-F5302BD5-A0A3-4A09-8A1D-F1B23325C530
P2860
Degradation of porstaglandin F2alpha in the human pulmonary circulation.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
Degradation of porstaglandin F2alpha in the human pulmonary circulation.
@ast
Degradation of porstaglandin F2alpha in the human pulmonary circulation.
@en
type
label
Degradation of porstaglandin F2alpha in the human pulmonary circulation.
@ast
Degradation of porstaglandin F2alpha in the human pulmonary circulation.
@en
prefLabel
Degradation of porstaglandin F2alpha in the human pulmonary circulation.
@ast
Degradation of porstaglandin F2alpha in the human pulmonary circulation.
@en
P2093
P2860
P356
P1433
P1476
Degradation of porstaglandin F2alpha in the human pulmonary circulation.
@en
P2093
P2860
P304
P356
10.1136/THX.31.6.713
P407
P577
1976-12-01T00:00:00Z